This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Azzopardi, D. Articles by Cheadle, J. P. Search for Related Content PubMed PubMed Citation Articles by Azzopardi, D. Articles by Cheadle, J. P.

Multiple Rare Nonsynonymous Variants in the Adenomatous Polyposis Coli Gene Predispose to Colorectal Adenomas

¹ Institute of Medical Genetics and ² Biostatistics and Bioinformatics Unit, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom; ³ Myriad Genetic Laboratories, Inc., Salt Lake City, Utah; and ⁴ Genzyme Genetics, Westborough, Massachusetts

Requests for reprints: Jeremy P. Cheadle, Institute of Medical Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, United Kingdom. Phone: 44-29-20742652; Fax: 44-29-20746551; E-mail: cheadlejp{at}cardiff.ac.uk.

It has been proposed that multiple rare variants in numerous genes collectively account for a substantial proportion of multifactorial inherited predisposition to a variety of diseases, including colorectal adenomas (CRA). We have studied this hypothesis by sequencing the adenomatous polyposis coli (APC) gene in 691 unrelated North American patients with CRAs and 969 matched healthy controls. Rare inherited nonsynonymous variants of APC were significantly overrepresented in patients who did not carry conventional pathogenic mutations in the APC or MutY homologue genes [non–familial adenomatous polyposis (FAP) non–MUTYH-associated polyposis (MAP) patients; 81 of 480, 16.9%] compared with patients with FAP or MAP (20 of 211, 9.5%, P = 0.0113), and this overrepresentation was highest in those non-FAP non-MAP patients with 11 to 99 CRAs (30 of 161, 18.6%, P = 0.0103). Furthermore, significantly more non-FAP non-MAP patients carried rare nonsynonymous variants in the functionally important β-catenin down-regulating domain compared with healthy controls (32 of 480 versus 37 of 969, P = 0.0166). In silico analyses predicted that 46% of the 61 different variants identified were likely to affect function, and upon testing, 7 of 16 nonsynonymous variants were shown to alter β-catenin–regulated transcription in vitro. These data suggest that multiple rare nonsynonymous variants in APC play a significant role in predisposing to CRAs. [Cancer Res 2008;68(2):358–63]

This article has been cited by other articles:

				A. Kaufmann, S. Vogt, S. Uhlhaas, D. Stienen, I. Kurth, H. Hameister, E. Mangold, J. Kotting, E. Kaminsky, P. Propping, et al. Analysis of Rare APC Variants at the mRNA Level: Six Pathogenic Mutations and Literature Review J. Mol. Diagn., March 1, 2009; 11(2): 131 - 139. [Abstract] [Full Text] [PDF]

				J. B. Egan, E. T. Jacobs, M. E. Martinez, E. W. Gerner, P. W. Jurutka, and P. A. Thompson Presence of a TA Haplotype in the APC Gene Containing the Common 1822 Polymorphism and Colorectal Adenoma Cancer Res., July 15, 2008; 68(14): 6006 - 6013. [Abstract] [Full Text] [PDF]